NICE says the combination’s cost-effectiveness estimate is higher than what is considered acceptable for NHS use

FoundationOne Liquid CDx analyses more than 300 cancer-related genes and multiple genomic signatures to help inform treatment decisions […]

A survey by GSK Consumer Healthcare and Ipsos MORI also signals a shift towards self-education and reducing the […]

Since autumn 2019, the Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF-funded ERA-NET project “NExT” that aims […]

The novel STAR assay can rapidly determine telomere dysregulation in cancers and age-related diseases in clinical settings.

A new type of breast cancer drug can help halt progression of disease and is not toxic, according […]

An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight […]

A new study looked at how pharmacogenomics could improve the safety and effectiveness of COVID-19 drug therapies.

Researchers are preparing to launch clinical trials of a drug used to cure a deadly disease caused by […]

Blenrep is a first-line inhibitor of BCMA, a cell-surface protein that plays a crucial role in the survival […]